Evidence map›Paper›PMID 40580352›Full record

ArticleAging clinical and experimental research2025

A concise instrument for screening cognitive impairment: validation in a geriatric population.

Ayse Dikmeer, Suna Burkuk, Pelin Unsal, Mert Polat, Cafer Balci, Meltem Halil, Mustafa Cankurtaran, Burcu Balam Dogu

Abstract readValidation Study
In one paragraph

Article in Aging clinical and experimental research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Bedside cognitive screening to detect dementia and predict poor outcomes in hospitals.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ayse DikmeerFaculty of Medicine, Department of Internal Medicine, Division of Geriatrics, Hacettepe University, Ankara, Turkey. adikmeer@yahoo.com.ORCID https://orcid.org/0000-0003-3016-8173
Suna BurkukFaculty of Medicine, Department of Internal Medicine, Division of Geriatrics, Hacettepe University, Ankara, Turkey.
Pelin UnsalFaculty of Medicine, Department of Internal Medicine, Division of Geriatrics, Hacettepe University, Ankara, Turkey.
Mert PolatFaculty of Medicine, Lokman Hekim University, Ankara, Turkey.
Cafer BalciFaculty of Medicine, Department of Internal Medicine, Division of Geriatrics, Hacettepe University, Ankara, Turkey.
Meltem HalilFaculty of Medicine, Department of Internal Medicine, Division of Geriatrics, Hacettepe University, Ankara, Turkey.
Mustafa CankurtaranFaculty of Medicine, Department of Internal Medicine, Division of Geriatrics, Hacettepe University, Ankara, Turkey.
Burcu Balam DoguFaculty of Medicine, Department of Internal Medicine, Division of Geriatrics, Hacettepe University, Ankara, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Short Portable Mental Status Questionnaire (SPMSQ) is a brief instrument designed to evaluate cognitive impairment in older adults. This study evaluates the validity and reliability of the Turkish SPMSQ and determines optimal cut-off values.

methodsPatients aged 65 years and older were enrolled consecutively. Following the translation and cultural adaptation procedure, the Turkish versions of the SPMSQ and Standardised Mini Mental State Examination (SMMSE) were administered to evaluate cognitive status. The SPMSQ's diagnostic accuracy was evaluated by calculating the area under ROC curve (AUC).

resultsA total of 197 patients were included, comprising 48 with dementia and 149 controls. In 67% of the study population, total education time was under five years. ROC analysis of the overall study population identified an optimal cut-off point of the SPMSQ for differentiating dementia at ≥ 4 errors, yielding a sensitivity of 83.3% and specificity of 90.6% (AUC: 0.949). The cut-off point was determined as ≥ 4 errors for patients with ≤ 5 years of education time (sensitivity: 87.2%, specificity: 84.9%, AUC: 0.933) and ≥ 3 errors for patients with > 5 years of education time (sensitivity: 100%, specificity: 98.2%, AUC: 0.997). The SPMSQ and SMMSE scores showed a significant positive correlation (r = 0.661, p < 0.001). The cut-off point for the SMMSE was ≤ 25, demonstrating 83.3% sensitivity and 97.3% specificity, with an AUC of 0.947. This was not statistically different from the SPMSQ AUC (p = 0.93).

conclusionThe SPMSQ is a reliable instrument for dementia screening in older adults and is not inferior to SMMSE. These findings suggest that the SPMSQ can be effectively utilized in primary care and geriatric clinics as a quick and reliable cognitive screening tool, especially in populations with varying education levels.

Indexed as

Cognitive DysfunctionGeriatric AssessmentAgedAged, 80 and overDementiaFemaleHumansMaleMass ScreeningMental Status and Dementia TestsNeuropsychological TestsReproducibility of ResultsROC CurveSensitivity and SpecificitySurveys and QuestionnairesTurkeyCognitive screeningDementiaReliability and validity

Identifiers

PMID40580352
PMCPMC12206163

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.